/Investor DB

Trinity Innovation Bioventure Singapore

Venture capital

Singapore · Seed–Late Stage · 3 people tracked

Find your way into Trinity Innovation Bioventure Singapore

197 people in our graph can introduce you to the Trinity Innovation Bioventure Singapore team.

Sign up to see every warm intro you have to Trinity Innovation Bioventure Singapore

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Trinity Innovation Bioventure Singapore team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

The firm is a licensed biomed venture capital fund pursuing innovation and value investment, drawing on deep insight and experience in Asian markets. It is part of the Trinity Innovation Fund group, founded in 2018, which manages multiple VC funds across the region. The team is led by industry veterans who have run several VC funds and invested in dozens of biotech companies.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
HQ
Singapore, SG
Leads rounds
Follows
Instruments
Equity
Founded
2018
Tracked investments
5

Team · 3 people

from public directories

What they invest in

from 2 of 5 portfolio companies

AI & Machine Learning ×2Biotech ×2Healthtech ×2Deep Tech ×1Medical Devices ×1

HQs:China×1

Investments · 5 tracked

founders shown can be your intro path
Epigenic Therapeuticsepigenictx.comin

Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Chloe You(Chief Medical Officer)inKelly Shi(Chief Financial Officer)

Co-investorsOrbiMedQiming Venture Partners

HiFiBiO Therapeuticshifibio.comin𝕏

HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics.

AI & Machine LearningBiotechHealthtech

Liang Schweizer(Founder)in

Co-investorsB Capital GroupB4 CapitalIDG CapitalLegend CapitalLYFE CapitalNest.Bio Ventures+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Avadel PharmaceuticalsRibo Life ScienceShanghai Argo Biopharmaceutical

Frequently asked questions

How many investments has Trinity Innovation Bioventure Singapore made?
Trinity Innovation Bioventure Singapore has 5 tracked investments.
What stage does Trinity Innovation Bioventure Singapore invest at?
Trinity Innovation Bioventure Singapore invests at the Seed, Series A, Growth, Late Stage stages.
What sectors does Trinity Innovation Bioventure Singapore focus on?
Trinity Innovation Bioventure Singapore focuses on Biotech, Digital Health, Medical Devices, Sector Agnostic.
Where is Trinity Innovation Bioventure Singapore located?
Trinity Innovation Bioventure Singapore is headquartered in Singapore, SG.
Does Trinity Innovation Bioventure Singapore lead rounds?
Trinity Innovation Bioventure Singapore typically participates in rounds rather than leading them.
Who does Trinity Innovation Bioventure Singapore co-invest with?
Trinity Innovation Bioventure Singapore most often shares deals with B Capital Group, B4 Capital, OrbiMed, among 6 tracked co-investors.

Similar investors

Featured in lists